175 related articles for article (PubMed ID: 22072013)
1. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis.
Boumans MJ; Thurlings RM; Yeo L; Scheel-Toellner D; Vos K; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jan; 71(1):108-13. PubMed ID: 22072013
[TBL] [Abstract][Full Text] [Related]
2. Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome.
Haynes D; Crotti T; Weedon H; Slavotinek J; Au V; Coleman M; Roberts-Thomson PJ; Ahern M; Smith MD
Arthritis Rheum; 2008 Jul; 59(7):911-20. PubMed ID: 18576301
[TBL] [Abstract][Full Text] [Related]
3. Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.
Rooney T; Edwards CK; Gogarty M; Greenan L; Veale DJ; FitzGerald O; Dayer JM; Bresnihan B
Rheumatol Int; 2010 Nov; 30(12):1571-80. PubMed ID: 19847430
[TBL] [Abstract][Full Text] [Related]
4. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
5. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
Revu S; Neregård P; af Klint E; Korotkova M; Catrina AI
Arthritis Res Ther; 2013; 15(6):R205. PubMed ID: 24295447
[TBL] [Abstract][Full Text] [Related]
6. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
[TBL] [Abstract][Full Text] [Related]
7. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
8. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.
Engvall IL; Svensson B; Boonen A; van der Heijde D; Lerner UH; Hafström I;
Rheumatology (Oxford); 2013 Apr; 52(4):733-42. PubMed ID: 23275387
[TBL] [Abstract][Full Text] [Related]
9. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
11. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
[TBL] [Abstract][Full Text] [Related]
12. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
13. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
14. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
15. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
16. Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study.
Hein G; Eidner T; Oelzner P; Rose M; Wilke A; Wolf G; Franke S
Rheumatol Int; 2011 Feb; 31(2):269-72. PubMed ID: 20661741
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.
Vis M; Havaardsholm EA; Haugeberg G; Uhlig T; Voskuyl AE; van de Stadt RJ; Dijkmans BA; Woolf AD; Kvien TK; Lems WF
Ann Rheum Dis; 2006 Nov; 65(11):1495-9. PubMed ID: 16606653
[TBL] [Abstract][Full Text] [Related]
18. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
[TBL] [Abstract][Full Text] [Related]
20. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
